Carbapenemases are β-lactamase enzymes that hydrolyze a variety of β-lactams including
carbapenem and belong to different Ambler classes (A, B, D). These enzymes can be …

Background Antibiotic use is largely under-regulated in Egypt leading to the emergence of
resistant isolates. Carbapenems are last resort agents to treat Acinetobacter baumannii …

Carbapenem-resistant Acinetobacter baumannii (CRAB) has been considered as an
important pathogen causing hospital-acquired infections thought the world. Class A …

Background and objective Acinetobacter baumannii (A. baumannii) is a common
nosocomial pathogen, which developed multi-drug-resistance to different classes of …

Abstract Purpose: Carbapenem resistance in Acinetobacter baumannii has become highly
rampant, which has been ascribed to the presence of multiple carbapenemases. The …

Objectives We investigated the molecular epidemiology of carbapenem-resistant
Acinetobacter baumannii from a Taiwanese hospital and determined the mechanisms …

Acinetobacter baumannii is a Gram-negative, glucose-non-fermenting, oxidase-negative
coccobacillus, most commonly associated with the hospital settings. The ability to survive in …

The increasing number of carbapenem-resistant Acinetobacter baumannii clinical isolates is
a major concern, which restricts therapeutic options for treatment of serious infections …

Objectives We have investigated the molecular epidemiology and distribution of
carbapenemase genes in 492 imipenem-non-susceptible Acinetobacter baumannii …

Multidrug-resistant Acinetobacter baumannii (MDRAB) is an increasing problem worldwide.
Prevalence of carbapenem resistance in Acinetobacter spp. due to acquired …